Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
12
NVNO Quote, Financials, Valuation and Earnings
Last price:
$0.35
Seasonality move
:
0.67%
Day range:
$0.32 - $0.34
52-week range:
$0.30 - $5.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
473.07x
P/B ratio:
0.22x
Volume:
568.8K
Avg. volume:
805.4K
1-year change:
-86.94%
Market cap:
$6.6M
Revenue:
--
EPS (TTM):
-$1.13
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NVNO
enVVeno Medical Corp.
|
-- | -$0.28 | -- | -9.68% | $12.50 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.5M | -- | -54.48% | -57.14% | $2.23 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
SINT
SINTX Technologies, Inc.
|
$200K | -$0.55 | -44.65% | -56.43% | $12.25 |
|
XAIR
Beyond Air, Inc.
|
$2.5M | -$0.26 | 243.81% | -8.29% | $10.33 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NVNO
enVVeno Medical Corp.
|
$0.33 | $12.50 | $6.6M | -- | $0.00 | 0% | 473.07x |
|
IVF
INVO Fertility, Inc.
|
$0.88 | -- | $13.3M | -- | $0.00 | 0% | 0.02x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.80 | $2.23 | $40.5M | -- | $0.00 | 0% | 2.67x |
|
NTRB
Nutriband, Inc.
|
$4.38 | $15.00 | $53.2M | -- | $0.00 | 0% | 21.86x |
|
SINT
SINTX Technologies, Inc.
|
$3.59 | $12.25 | $13.8M | -- | $0.00 | 0% | 6.09x |
|
XAIR
Beyond Air, Inc.
|
$0.92 | $10.33 | $4.3M | -- | $0.00 | 0% | 4.12x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NVNO
enVVeno Medical Corp.
|
2.62% | 2.197 | 4.32% | 12.90x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 2.039 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 2.796 | 0.32% | 7.07x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 1.079 | 22.94% | 1.47x |
|
XAIR
Beyond Air, Inc.
|
48.09% | 1.510 | 106.48% | 2.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NVNO
enVVeno Medical Corp.
|
-$120K | -$4.9M | -56.26% | -57.7% | -- | -$4.4M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
|
XAIR
Beyond Air, Inc.
|
-$298K | -$7.7M | -126.53% | -220.61% | -421.4% | -$4.7M |
enVVeno Medical Corp. vs. Competitors
-
Which has Higher Returns NVNO or IVF?
INVO Fertility, Inc. has a net margin of -- compared to enVVeno Medical Corp.'s net margin of -150.51%. enVVeno Medical Corp.'s return on equity of -57.7% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical Corp.-- -$0.23 $30.2M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About NVNO or IVF?
enVVeno Medical Corp. has a consensus price target of $12.50, signalling upside risk potential of 3744.97%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 16237.64%. Given that INVO Fertility, Inc. has higher upside potential than enVVeno Medical Corp., analysts believe INVO Fertility, Inc. is more attractive than enVVeno Medical Corp..
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical Corp.0 1 0 IVFINVO Fertility, Inc.0 0 0 -
Is NVNO or IVF More Risky?
enVVeno Medical Corp. has a beta of 1.063, which suggesting that the stock is 6.264% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock NVNO or IVF?
enVVeno Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical Corp. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or IVF?
enVVeno Medical Corp. quarterly revenues are --, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. enVVeno Medical Corp.'s net income of -$4.5M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, enVVeno Medical Corp.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical Corp. is 473.07x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M IVFINVO Fertility, Inc.0.02x -- $1.8M -$2.6M
-
Which has Higher Returns NVNO or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -- compared to enVVeno Medical Corp.'s net margin of -59.08%. enVVeno Medical Corp.'s return on equity of -57.7% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical Corp.-- -$0.23 $30.2M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About NVNO or NMTC?
enVVeno Medical Corp. has a consensus price target of $12.50, signalling upside risk potential of 3744.97%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 176.78%. Given that enVVeno Medical Corp. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe enVVeno Medical Corp. is more attractive than NeuroOne Medical Technologies Corp..
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical Corp.0 1 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is NVNO or NMTC More Risky?
enVVeno Medical Corp. has a beta of 1.063, which suggesting that the stock is 6.264% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.
-
Which is a Better Dividend Stock NVNO or NMTC?
enVVeno Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical Corp. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or NMTC?
enVVeno Medical Corp. quarterly revenues are --, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. enVVeno Medical Corp.'s net income of -$4.5M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, enVVeno Medical Corp.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical Corp. is 473.07x versus 2.67x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M NMTCNeuroOne Medical Technologies Corp.2.67x -- $2.7M -$1.6M
-
Which has Higher Returns NVNO or NTRB?
Nutriband, Inc. has a net margin of -- compared to enVVeno Medical Corp.'s net margin of -1118.87%. enVVeno Medical Corp.'s return on equity of -57.7% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical Corp.-- -$0.23 $30.2M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About NVNO or NTRB?
enVVeno Medical Corp. has a consensus price target of $12.50, signalling upside risk potential of 3744.97%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 242.47%. Given that enVVeno Medical Corp. has higher upside potential than Nutriband, Inc., analysts believe enVVeno Medical Corp. is more attractive than Nutriband, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical Corp.0 1 0 NTRBNutriband, Inc.1 0 0 -
Is NVNO or NTRB More Risky?
enVVeno Medical Corp. has a beta of 1.063, which suggesting that the stock is 6.264% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock NVNO or NTRB?
enVVeno Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical Corp. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or NTRB?
enVVeno Medical Corp. quarterly revenues are --, which are smaller than Nutriband, Inc. quarterly revenues of $346.1K. enVVeno Medical Corp.'s net income of -$4.5M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, enVVeno Medical Corp.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical Corp. is 473.07x versus 21.86x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M NTRBNutriband, Inc.21.86x -- $346.1K -$3.9M
-
Which has Higher Returns NVNO or SINT?
SINTX Technologies, Inc. has a net margin of -- compared to enVVeno Medical Corp.'s net margin of -1701.44%. enVVeno Medical Corp.'s return on equity of -57.7% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical Corp.-- -$0.23 $30.2M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About NVNO or SINT?
enVVeno Medical Corp. has a consensus price target of $12.50, signalling upside risk potential of 3744.97%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 241.23%. Given that enVVeno Medical Corp. has higher upside potential than SINTX Technologies, Inc., analysts believe enVVeno Medical Corp. is more attractive than SINTX Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical Corp.0 1 0 SINTSINTX Technologies, Inc.2 0 0 -
Is NVNO or SINT More Risky?
enVVeno Medical Corp. has a beta of 1.063, which suggesting that the stock is 6.264% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.
-
Which is a Better Dividend Stock NVNO or SINT?
enVVeno Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical Corp. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or SINT?
enVVeno Medical Corp. quarterly revenues are --, which are smaller than SINTX Technologies, Inc. quarterly revenues of $208K. enVVeno Medical Corp.'s net income of -$4.5M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, enVVeno Medical Corp.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical Corp. is 473.07x versus 6.09x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M SINTSINTX Technologies, Inc.6.09x -- $208K -$3.5M
-
Which has Higher Returns NVNO or XAIR?
Beyond Air, Inc. has a net margin of -- compared to enVVeno Medical Corp.'s net margin of -454.24%. enVVeno Medical Corp.'s return on equity of -57.7% beat Beyond Air, Inc.'s return on equity of -220.61%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical Corp.-- -$0.23 $30.2M XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M -
What do Analysts Say About NVNO or XAIR?
enVVeno Medical Corp. has a consensus price target of $12.50, signalling upside risk potential of 3744.97%. On the other hand Beyond Air, Inc. has an analysts' consensus of $10.33 which suggests that it could grow by 1022.21%. Given that enVVeno Medical Corp. has higher upside potential than Beyond Air, Inc., analysts believe enVVeno Medical Corp. is more attractive than Beyond Air, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical Corp.0 1 0 XAIRBeyond Air, Inc.2 1 0 -
Is NVNO or XAIR More Risky?
enVVeno Medical Corp. has a beta of 1.063, which suggesting that the stock is 6.264% more volatile than S&P 500. In comparison Beyond Air, Inc. has a beta of 0.304, suggesting its less volatile than the S&P 500 by 69.581%.
-
Which is a Better Dividend Stock NVNO or XAIR?
enVVeno Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical Corp. pays -- of its earnings as a dividend. Beyond Air, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or XAIR?
enVVeno Medical Corp. quarterly revenues are --, which are smaller than Beyond Air, Inc. quarterly revenues of $1.8M. enVVeno Medical Corp.'s net income of -$4.5M is higher than Beyond Air, Inc.'s net income of -$8.3M. Notably, enVVeno Medical Corp.'s price-to-earnings ratio is -- while Beyond Air, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical Corp. is 473.07x versus 4.12x for Beyond Air, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M XAIRBeyond Air, Inc.4.12x -- $1.8M -$8.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
